Susceptibility genes and B-chronic lymphocytic leukaemia

Susan L Slager, Neil Elliot Kay, Zachary S. Fredericksen, Alice H. Wang, Mark Liebow, Julie M Cunningham, Celine M Vachon, Timothy G. Call, James R Cerhan

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Common genetic variants are thought to increase the risk of chronic lymphocytic leukaemia (CLL), and case-control studies provide an approach to detect these variants. There have been multiple candidate gene studies published to date, but relatively few disease pathway studies or large genomic association studies. We summarize the results of these previous studies, as well as present results from our recent large pathway study of 9412 single nucleotide polymorphisms from 1253 immunity and inflammation genes in a study of 126 CLL cases and 484 frequency-matched controls. Several promising genes have been identified as susceptibility genes for risk of CLL across all of these association studies. However, a number of candidate gene studies have not been replicated in follow-up studies, whereas the results from disease pathway and large genomic studies have yet to be replicated in an independent sample. The challenge of future studies of this type will be overcoming study design issues, including definition of CLL, sample size limitations and multiple testing issues.

Original languageEnglish (US)
Pages (from-to)762-771
Number of pages10
JournalBritish Journal of Haematology
Volume139
Issue number5
DOIs
StatePublished - Dec 2007

Fingerprint

B-Cell Chronic Lymphocytic Leukemia
Genes
Sample Size
Single Nucleotide Polymorphism
Case-Control Studies
Immunity
Inflammation

Keywords

  • Candidate gene
  • Case-control
  • Disease pathway
  • Genetic association
  • Genomic studies

ASJC Scopus subject areas

  • Hematology

Cite this

Susceptibility genes and B-chronic lymphocytic leukaemia. / Slager, Susan L; Kay, Neil Elliot; Fredericksen, Zachary S.; Wang, Alice H.; Liebow, Mark; Cunningham, Julie M; Vachon, Celine M; Call, Timothy G.; Cerhan, James R.

In: British Journal of Haematology, Vol. 139, No. 5, 12.2007, p. 762-771.

Research output: Contribution to journalArticle

@article{5f8fa1eac4484c8498b43f8a4dd12bb8,
title = "Susceptibility genes and B-chronic lymphocytic leukaemia",
abstract = "Common genetic variants are thought to increase the risk of chronic lymphocytic leukaemia (CLL), and case-control studies provide an approach to detect these variants. There have been multiple candidate gene studies published to date, but relatively few disease pathway studies or large genomic association studies. We summarize the results of these previous studies, as well as present results from our recent large pathway study of 9412 single nucleotide polymorphisms from 1253 immunity and inflammation genes in a study of 126 CLL cases and 484 frequency-matched controls. Several promising genes have been identified as susceptibility genes for risk of CLL across all of these association studies. However, a number of candidate gene studies have not been replicated in follow-up studies, whereas the results from disease pathway and large genomic studies have yet to be replicated in an independent sample. The challenge of future studies of this type will be overcoming study design issues, including definition of CLL, sample size limitations and multiple testing issues.",
keywords = "Candidate gene, Case-control, Disease pathway, Genetic association, Genomic studies",
author = "Slager, {Susan L} and Kay, {Neil Elliot} and Fredericksen, {Zachary S.} and Wang, {Alice H.} and Mark Liebow and Cunningham, {Julie M} and Vachon, {Celine M} and Call, {Timothy G.} and Cerhan, {James R}",
year = "2007",
month = "12",
doi = "10.1111/j.1365-2141.2007.06872.x",
language = "English (US)",
volume = "139",
pages = "762--771",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Susceptibility genes and B-chronic lymphocytic leukaemia

AU - Slager, Susan L

AU - Kay, Neil Elliot

AU - Fredericksen, Zachary S.

AU - Wang, Alice H.

AU - Liebow, Mark

AU - Cunningham, Julie M

AU - Vachon, Celine M

AU - Call, Timothy G.

AU - Cerhan, James R

PY - 2007/12

Y1 - 2007/12

N2 - Common genetic variants are thought to increase the risk of chronic lymphocytic leukaemia (CLL), and case-control studies provide an approach to detect these variants. There have been multiple candidate gene studies published to date, but relatively few disease pathway studies or large genomic association studies. We summarize the results of these previous studies, as well as present results from our recent large pathway study of 9412 single nucleotide polymorphisms from 1253 immunity and inflammation genes in a study of 126 CLL cases and 484 frequency-matched controls. Several promising genes have been identified as susceptibility genes for risk of CLL across all of these association studies. However, a number of candidate gene studies have not been replicated in follow-up studies, whereas the results from disease pathway and large genomic studies have yet to be replicated in an independent sample. The challenge of future studies of this type will be overcoming study design issues, including definition of CLL, sample size limitations and multiple testing issues.

AB - Common genetic variants are thought to increase the risk of chronic lymphocytic leukaemia (CLL), and case-control studies provide an approach to detect these variants. There have been multiple candidate gene studies published to date, but relatively few disease pathway studies or large genomic association studies. We summarize the results of these previous studies, as well as present results from our recent large pathway study of 9412 single nucleotide polymorphisms from 1253 immunity and inflammation genes in a study of 126 CLL cases and 484 frequency-matched controls. Several promising genes have been identified as susceptibility genes for risk of CLL across all of these association studies. However, a number of candidate gene studies have not been replicated in follow-up studies, whereas the results from disease pathway and large genomic studies have yet to be replicated in an independent sample. The challenge of future studies of this type will be overcoming study design issues, including definition of CLL, sample size limitations and multiple testing issues.

KW - Candidate gene

KW - Case-control

KW - Disease pathway

KW - Genetic association

KW - Genomic studies

UR - http://www.scopus.com/inward/record.url?scp=36148965219&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36148965219&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2141.2007.06872.x

DO - 10.1111/j.1365-2141.2007.06872.x

M3 - Article

C2 - 18021089

AN - SCOPUS:36148965219

VL - 139

SP - 762

EP - 771

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 5

ER -